Norepinephrine-targeted Therapy for Action Control in Parkinson Disease
Clinical trial NCT03115827 · COMPLETED
Trial details
- NCT number
- NCT03115827
- Sponsor
- Vanderbilt University Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-18
- Primary completion
- 2018-12-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.